US Patent 8814930 Biodegradable endoprosthesis and methods for their fabrication

Patent 8814930 was granted and assigned to Elixir Medical Corporation on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Elixir Medical Corporation

Current Assignee

‌

Elixir Medical Corporation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8814930

Date of Patent

August 26, 2014

Patent Application Number

13897302

Date Filed

May 17, 2013

Patent Citations Received

‌

US Patent 11890041 Flexible construct for femoral reconstruction

‌

US Patent 11931484 Composite stent having multi-axial flexibility and method of manufacture thereof

‌

US Patent 12011378 Uncaging stent

Patent Primary Examiner

‌

Alvin Stewart

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8814930 Biodegradable endoprosthesis and methods for their fabrication

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API